Michael Burgess actually said...

"It is especially important that, as we evaluate this legislation, we consider the possibility of unintended consequences for both the patient and for the market."

"We must strike this delicate balance with the policies that we pass through this committee to ensure that they do not dampen the success or deter future investment in biomedical research and innovatio..."

"We need to ensure that, as we work to shine a light on how drugs come to market and are priced, that we realize that the market must also be sustainable to produce the next generation of cures and tre..."

"In that light, I believe any policies pursued by this committee must put the patient front and center."